TYO:4568

Daiichi Sankyo Company Stock Earnings Reports

etoro logo Buy 4568
*Your capital is at risk
JP¥3,443.00
-38.00 (-1.09%)
At Close: Nov 18, 2025

DAIICHI SANKYO COMPANY Earnings Calls

Sep 30, 2025
JP¥25.56 (-45.30%)
Release date Oct 29, 2025
EPS estimate JP¥46.73
EPS actual JP¥25.56
EPS Surprise -45.30%
Revenue estimate 516.489B
Revenue actual 521.967B
Revenue Surprise 1.06%
Jun 30, 2025
JP¥47.18 (34.57%)
Release date Jul 29, 2025
EPS estimate JP¥35.06
EPS actual JP¥47.18
EPS Surprise 34.57%
Revenue estimate 472.21B
Revenue actual 474.597B
Revenue Surprise 0.506%
Mar 31, 2025
JP¥44.31 (137.97%)
Release date Apr 23, 2025
EPS estimate JP¥18.62
EPS actual JP¥44.31
EPS Surprise 137.97%
Revenue estimate 470.699B
Revenue actual 518.689B
Revenue Surprise 10.20%
Dec 31, 2024
JP¥32.32 (-0.615%)
Release date Jan 29, 2025
EPS estimate JP¥32.52
EPS actual JP¥32.32
EPS Surprise -0.615%
Revenue estimate 467.26B
Revenue actual 484.84B
Revenue Surprise 3.76%

Last 4 Quarters for DAIICHI SANKYO COMPANY

Below you can see how 4568.T performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Dec 31, 2024 Missed
Release date Jan 29, 2025
Price on release JP¥4,395.00
EPS estimate JP¥32.52
EPS actual JP¥32.32
EPS surprise -0.615%
Date Price
Jan 23, 2025 JP¥4,428.00
Jan 24, 2025 JP¥4,330.00
Jan 27, 2025 JP¥4,388.00
Jan 28, 2025 JP¥4,452.00
Jan 29, 2025 JP¥4,395.00
Jan 30, 2025 JP¥4,412.00
Jan 31, 2025 JP¥4,277.00
Feb 03, 2025 JP¥4,117.00
Feb 04, 2025 JP¥4,017.00
4 days before -0.745%
4 days after -8.60%
On release day 0.387%
Change in period -9.28%
Mar 31, 2025 Beat
Release date Apr 23, 2025
Price on release JP¥3,288.00
EPS estimate JP¥18.62
EPS actual JP¥44.31
EPS surprise 137.97%
Date Price
Apr 17, 2025 JP¥3,100.00
Apr 18, 2025 JP¥3,214.00
Apr 21, 2025 JP¥3,184.00
Apr 22, 2025 JP¥3,233.00
Apr 23, 2025 JP¥3,288.00
Apr 24, 2025 JP¥3,316.00
Apr 25, 2025 JP¥3,523.00
Apr 28, 2025 JP¥3,513.00
Apr 30, 2025 JP¥3,644.00
4 days before 6.06%
4 days after 10.83%
On release day 0.85%
Change in period 17.55%
Jun 30, 2025 Beat
Release date Jul 29, 2025
Price on release JP¥3,642.00
EPS estimate JP¥35.06
EPS actual JP¥47.18
EPS surprise 34.57%
Date Price
Jul 23, 2025 JP¥3,644.00
Jul 24, 2025 JP¥3,666.00
Jul 25, 2025 JP¥3,630.00
Jul 28, 2025 JP¥3,660.00
Jul 29, 2025 JP¥3,642.00
Jul 30, 2025 JP¥3,653.00
Jul 31, 2025 JP¥3,720.00
Aug 01, 2025 JP¥3,678.00
Aug 04, 2025 JP¥3,620.00
4 days before -0.0549%
4 days after -0.604%
On release day 0.302%
Change in period -0.659%
Sep 30, 2025 Missed
Release date Oct 29, 2025
Price on release JP¥3,865.00
EPS estimate JP¥46.73
EPS actual JP¥25.56
EPS surprise -45.30%
Date Price
Oct 23, 2025 JP¥4,057.00
Oct 24, 2025 JP¥4,005.00
Oct 27, 2025 JP¥3,999.00
Oct 28, 2025 JP¥3,979.00
Oct 29, 2025 JP¥3,865.00
Oct 30, 2025 JP¥3,842.00
Oct 31, 2025 JP¥3,669.00
Nov 04, 2025 JP¥3,370.00
Nov 05, 2025 JP¥3,369.00
4 days before -4.73%
4 days after -12.83%
On release day -0.595%
Change in period -16.96%

DAIICHI SANKYO COMPANY Earnings History

Earnings Calendar

FAQ

When is the earnings report for 4568.T?
DAIICHI SANKYO COMPANY,LIMITED (4568.T) has scheduled its earnings report for Jan 28, 2026 before the markets open.

What is the 4568.T price-to-earnings (P/E) ratio?
4568.T P/E ratio as of Nov 18, 2025 (TTM) is 21.85.

What is the 4568.T EPS forecast?
The forecasted EPS (Earnings Per Share) for DAIICHI SANKYO COMPANY,LIMITED (4568.T) for the first fiscal quarter 2026 is JP¥.

What are DAIICHI SANKYO COMPANY,LIMITED's retained earnings?
On its balance sheet, DAIICHI SANKYO COMPANY,LIMITED reported retained earnings of JP¥0 for the latest quarter ending Jun 30, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT DAIICHI SANKYO COMPANY,LIMITED
DAIICHI SANKYO COMPANY
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders;...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE